Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drbal

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neoplasma|January 1, 1989
High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot studyP Opat, J Drbal, R Vyzula
European Journal of Cancer & Clinical Oncology|August 1, 1988
Alteration of beta-2-microglobulin level in malignant lymphoproliferative diseases after a high dose of alpha-2-recombinant interferonP Opat, J Drbal, Z Tauer, et al.
Vnitrni Lekarstvi|August 22, 2000
[Erythema exsudativum multiforme with macroglobulinemia]Z Churý, J Drbal, H Jedlicková, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapyJ Tomandl, V Palyza, J Tallová, et al.
Vnitrni Lekarstvi|September 1, 1987
[Malignant lymphogranuloma and pericarditis]R Vyzula, P Opat, J Drbal, et al.
Vnitrni Lekarstvi|October 1, 1988
[Relation of beta 2 microglobulin and favorable therapeutic responses in malignant lymphoproliferative diseases]P Opat, J Drbal, R Vyzula, et al.
Vnitrni Lekarstvi|September 29, 1998
[Fatty acid and cholesterol crystals in bone marrow smears of oncology patients]Z Churý, J Drbal, J Kalabis, et al.
Neoplasma|September 14, 2000
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer InstituteJ Petera, H Macharová, R Pohanková, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancerJ M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neoplasma|January 1, 1989
High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot studyP Opat, J Drbal, R Vyzula
European Journal of Cancer & Clinical Oncology|August 1, 1988
Alteration of beta-2-microglobulin level in malignant lymphoproliferative diseases after a high dose of alpha-2-recombinant interferonP Opat, J Drbal, Z Tauer, et al.
Vnitrni Lekarstvi|August 22, 2000
[Erythema exsudativum multiforme with macroglobulinemia]Z Churý, J Drbal, H Jedlicková, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapyJ Tomandl, V Palyza, J Tallová, et al.
Vnitrni Lekarstvi|September 1, 1987
[Malignant lymphogranuloma and pericarditis]R Vyzula, P Opat, J Drbal, et al.
Vnitrni Lekarstvi|October 1, 1988
[Relation of beta 2 microglobulin and favorable therapeutic responses in malignant lymphoproliferative diseases]P Opat, J Drbal, R Vyzula, et al.
Vnitrni Lekarstvi|September 29, 1998
[Fatty acid and cholesterol crystals in bone marrow smears of oncology patients]Z Churý, J Drbal, J Kalabis, et al.
Neoplasma|September 14, 2000
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer InstituteJ Petera, H Macharová, R Pohanková, et al.
Oncology (Williston Park, N.Y.)|August 1, 1997
Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancerJ M Nabholtz, B Thuerlimann, W R Bezwoda, et al.
Vnitrni Lekarstvi|September 28, 1998
[Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group]Z Adam, M Krejcí, J Bacovský, et al.
Pageof 2